2022
DOI: 10.1016/j.canrad.2021.08.001
|View full text |Cite
|
Sign up to set email alerts
|

Delineation of organs at risk

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 82 publications
0
2
0
Order By: Relevance
“…Many established dose-volume tolerance levels included in various guidelines, e.g. QUANTEC [53] , [69] or RTOG [70] , [71] , [72] , cannot be applied for hypo-fractionated regimen. Only one normal tissue complication probability model for choroidal melanoma post-proton therapy exits [42] .…”
Section: Discussionmentioning
confidence: 99%
“…Many established dose-volume tolerance levels included in various guidelines, e.g. QUANTEC [53] , [69] or RTOG [70] , [71] , [72] , cannot be applied for hypo-fractionated regimen. Only one normal tissue complication probability model for choroidal melanoma post-proton therapy exits [42] .…”
Section: Discussionmentioning
confidence: 99%
“…The success of these treatments and the reduced toxicity highly rely on the exact definition of the different OARs ( 13 , 14 ). Radiation oncologists generally follow the established guidelines to define the volume of interest ( 15 17 ). The common practice is to manually draw the contours of different organs on the MR images.…”
Section: Introductionmentioning
confidence: 99%